Literature DB >> 12376818

An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.

Tsukasa Takemura1, Mitsuru Okada, Kazuro Yagi, Hiroaki Kuwajima, Hidehiko Yanagida.   

Abstract

We describe a patient with IgA nephropathy associated with Crohn disease. IgA nephropathy first appeared at the age of 10 years. Combined therapy with prednisolone, cyclophosphamide, warfarin, and angiotensin-converting enzyme inhibitor resulted in clinical improvement over the following year, and remission was maintained. At the age of 13 years, the patient developed Crohn disease and IgA nephropathy recurred. Significant increases in serum IgA were associated with progression of Crohn disease. An elemental diet combined with oral prednisolone resulted in clinical improvement of Crohn disease and in remission of nephropathy and normalization of serum IgA concentration. The clinical course of the two diseases was linked, suggesting a common pathogenetic mechanism involving an IgA immune response to mucosal challenge in the intestine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376818     DOI: 10.1007/s00467-002-0943-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  IgA nephropathy in association with Crohn's disease.

Authors:  M J Forshaw; O Guirguis; T W Hennigan
Journal:  Int J Colorectal Dis       Date:  2005-01-25       Impact factor: 2.571

2.  Recurrent IgA nephropathy complicated with Crohn's disease after renal transplantation.

Authors:  Midori Hasegawa; Hitomi Sasaki; Kazuo Takahashi; Hiroki Hayashi; Shigehisa Koide; Makoto Tomita; Asami Takeda; Kiyotaka Hoshinaga; Yukio Yuzawa
Journal:  CEN Case Rep       Date:  2014-02-16

3.  Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.

Authors:  Tara K Sigdel; Sang Hoon Woo; Hong Dai; Purvesh Khatri; Li Li; Bryan Myers; Minnie M Sarwal; Richard A Lafayette
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

4.  Infliximab treatment for Crohn's disease in a patient with IgA nephropathy.

Authors:  Yoshitaka Ueno; Shinji Tanaka; Toshiko Onitake; Rie Hanaoka; Kyoko Yoshioka; Masanori Ito; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2009-10-03

5.  Immunoglobulin A nephropathy complicating ulcerative colitis.

Authors:  Aideloje Onime; Emmanuel I Agaba; Yijuan Sun; Robert B Parsons; Karen S Servilla; Larry W Massie; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

6.  The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease.

Authors:  Josephine M Ambruzs; Patrick D Walker; Christopher P Larsen
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

7.  Henoch-Schonlein purpura antecedent to Crohn's disease.

Authors:  Galit Pomeranz; Tania Zehavi; Yosef Uziel; Avishalom Pomeranz; Ze'ev Korzets
Journal:  SAGE Open Med Case Rep       Date:  2015-10-12

8.  A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn's disease.

Authors:  Ji-Young Choi; Chung Hoon Yu; Hee-Yeon Jung; Min Kyu Jung; Yong-Jin Kim; Jang-Hee Cho; Chan-Duck Kim; Yong-Lim Kim; Sun-Hee Park
Journal:  BMC Nephrol       Date:  2012-08-06       Impact factor: 2.388

9.  Renal involvement in children and adolescents with inflammatory bowel disease.

Authors:  Hea Min Jang; Hee Sun Baek; Jung-Eun Kim; Ju Young Kim; Yeon Hee Lee; Hee Yeon Cho; Yon Ho Choe; Ben Kang; Byung-Ho Choe; Bong Seok Choi; Min Hyun Cho
Journal:  Korean J Pediatr       Date:  2018-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.